TOVX icon

Theriva Biologics

9 hedge funds and large institutions have $60.3K invested in Theriva Biologics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 9 closing their positions.

Holders
9
Holders Change
-8
Holders Change %
-47.06%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
2
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
UBS Group
1
UBS Group
Switzerland
$28.7K 16,406 -1,445 -8%
Citigroup
2
Citigroup
New York
$13.6K 7,756 +7,756 New
BlackRock
3
BlackRock
New York
$13.2K 7,568
TRCT
4
Tower Research Capital (TRC)
New York
$2.44K 1,391 +730 +110%
Osaic Holdings
5
Osaic Holdings
Arizona
$2.26K 1,294
Bank of America
6
Bank of America
North Carolina
$35 20 +11 +122%
IHWM
7
Iron Horse Wealth Management
Iowa
$25 14
IA
8
IFP Advisors
Florida
$19 11 -296 -96%
SS
9
SBI Securities
Japan
$18 10 +10 New
HCM
10
Heights Capital Management
California
-141,958 Closed
AFM
11
Anson Funds Management
Texas
-139,046 Closed
AC
12
Armistice Capital
New York
-100,000 Closed
MP
13
MSD Partners
New York
-27,316 Closed
Morgan Stanley
14
Morgan Stanley
New York
-20,200 Closed
Two Sigma Investments
15
Two Sigma Investments
New York
-13,566 Closed
HF
16
HRT Financial
New York
-11,806 Closed
TSS
17
Two Sigma Securities
New York
-10,120 Closed
Barclays
18
Barclays
United Kingdom
-495 Closed
CFGS
19
Concourse Financial Group Securities
Alabama